Keywords: elixir, licenses, myolimus, novartis, firm, medical, entered

Elixir licenses Myolimus from Novartis

Article | 20 October 2008

Print This

US firm Elixir Medical has entered into a co-exclusive worldwide license agreement with Swiss drug major Novartis for the rights ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in